Barrow, Hanley, Mewhinney & Strauss’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8K Sell
497
-79
-14% -$2.55K ﹤0.01% 205
2026
Q1
$14.2K Sell
576
-381
-40% -$9.06K ﹤0.01% 199
2025
Q4
$18K Sell
957
-85
-8% -$1.41K ﹤0.01% 174
2025
Q3
$15.5K Sell
1,042
-37
-3% -$529 ﹤0.01% 180
2025
Q2
$14.4K Sell
1,079
-333
-24% -$3.74K ﹤0.01% 171
2025
Q1
$14.2K Buy
1,412
+1,086
+333% +$11.5K ﹤0.01% 186
2024
Q4
$3.35K Buy
326
+250
+329% +$3.08K ﹤0.01% 279
2024
Q3
$1.24K Buy
+76
New +$1.29K ﹤0.01% 306

Other funds holding CSTM

Barrow, Hanley, Mewhinney & Strauss's CSTM Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss reduced its Constellium (CSTM) stake by 14% in Q2 2026, selling an estimated $2.55K and leaving 497 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #205.

Barrow, Hanley, Mewhinney & Strauss first reported a position in CSTM in Q3 2024 and has held it in 8 quarters since. The position peaked at $18K in Q4 2025. 388 funds tracked by Wall St. Rank hold CSTM as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 497 shares of Constellium worth $15.8K as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss sold 79 Constellium shares in Q2 2026, an estimated $2.55K.
  • Constellium made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #205 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Constellium in Q3 2024 and has held it in 8 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Constellium position peaked at $18K in Q4 2025.
  • 388 funds tracked by Wall St. Rank held Constellium as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.